580 related articles for article (PubMed ID: 19704410)
21. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
Livingstone DE; Walker BR
J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365
[TBL] [Abstract][Full Text] [Related]
22. Expression of genes related to glucocorticoid action in human subcutaneous and omental adipose tissue.
Veilleux A; Laberge PY; Morency J; Noël S; Luu-The V; Tchernof A
J Steroid Biochem Mol Biol; 2010 Oct; 122(1-3):28-34. PubMed ID: 20206259
[TBL] [Abstract][Full Text] [Related]
23. Weight loss after gastric bypass surgery in women is followed by a metabolically favorable decrease in 11beta-hydroxysteroid dehydrogenase 1 expression in subcutaneous adipose tissue.
Simonyte K; Olsson T; Näslund I; Angelhed JE; Lönn L; Mattsson C; Rask E
J Clin Endocrinol Metab; 2010 Jul; 95(7):3527-31. PubMed ID: 20410231
[TBL] [Abstract][Full Text] [Related]
24. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
[TBL] [Abstract][Full Text] [Related]
25. Omental 11beta-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity.
Michailidou Z; Jensen MD; Dumesic DA; Chapman KE; Seckl JR; Walker BR; Morton NM
Obesity (Silver Spring); 2007 May; 15(5):1155-63. PubMed ID: 17495191
[TBL] [Abstract][Full Text] [Related]
26. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR
J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378
[TBL] [Abstract][Full Text] [Related]
27. Expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 enzyme in subcutaneous and visceral adipose tissue of prepubertal children.
Mericq V; Medina P; Bouwman C; Johnson MC; Godoy J; López T; Iñiguez G
Horm Res; 2009; 71(2):89-93. PubMed ID: 19129713
[TBL] [Abstract][Full Text] [Related]
28. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
29. Deep subcutaneous adipose tissue: a distinct abdominal adipose depot.
Walker GE; Verti B; Marzullo P; Savia G; Mencarelli M; Zurleni F; Liuzzi A; Di Blasio AM
Obesity (Silver Spring); 2007 Aug; 15(8):1933-43. PubMed ID: 17712110
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women.
Goedecke JH; Wake DJ; Levitt NS; Lambert EV; Collins MR; Morton NM; Andrew R; Seckl JR; Walker BR
Clin Endocrinol (Oxf); 2006 Jul; 65(1):81-7. PubMed ID: 16817824
[TBL] [Abstract][Full Text] [Related]
31. Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome.
Gambineri A; Vicennati V; Genghini S; Tomassoni F; Pagotto U; Pasquali R; Walker BR
J Clin Endocrinol Metab; 2006 Jun; 91(6):2295-302. PubMed ID: 16551740
[TBL] [Abstract][Full Text] [Related]
32. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes.
Jang C; Obeyesekere VR; Dilley RJ; Krozowski Z; Inder WJ; Alford FP
J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316
[TBL] [Abstract][Full Text] [Related]
33. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.
Draper N; Walker EA; Bujalska IJ; Tomlinson JW; Chalder SM; Arlt W; Lavery GG; Bedendo O; Ray DW; Laing I; Malunowicz E; White PC; Hewison M; Mason PJ; Connell JM; Shackleton CH; Stewart PM
Nat Genet; 2003 Aug; 34(4):434-9. PubMed ID: 12858176
[TBL] [Abstract][Full Text] [Related]
34. Effect of hyperlipidemia on 11β-hydroxysteroid-dehydrogenase, glucocorticoid receptor, and leptin expression in insulin-sensitive tissues of cats.
Sieber-Ruckstuhl NS; Zini E; Osto M; Franchini M; Boretti FS; Meli ML; Sigrist B; Lutz TA; Reusch CE
Domest Anim Endocrinol; 2010 Nov; 39(4):222-30. PubMed ID: 20688460
[TBL] [Abstract][Full Text] [Related]
35. Body fat composition and distribution in women with polycystic ovary syndrome.
Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
[TBL] [Abstract][Full Text] [Related]
36. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
[TBL] [Abstract][Full Text] [Related]
37. The R453Q and D151A polymorphisms of hexose-6-phosphate dehydrogenase gene (H6PD) influence the polycystic ovary syndrome (PCOS) and obesity.
Martínez-García MA; San-Millán JL; Escobar-Morreale HF
Gene; 2012 Apr; 497(1):38-44. PubMed ID: 22306327
[TBL] [Abstract][Full Text] [Related]
38. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
39. Quantitative real-time PCR for the measurement of 11beta-HSD1 and 11beta-HSD2 mRNA levels in tissues of healthy dogs.
Sieber-Ruckstuhl NS; Meli ML; Boretti FS; Gönczi E; Lutz H; Reusch CE
Horm Metab Res; 2007 Aug; 39(8):548-54. PubMed ID: 17712718
[TBL] [Abstract][Full Text] [Related]
40. In vitro evidence that hyperglycemia stimulates tumor necrosis factor-alpha release in obese women with polycystic ovary syndrome.
González F; Rote NS; Minium J; Kirwan JP
J Endocrinol; 2006 Mar; 188(3):521-9. PubMed ID: 16522732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
